Company Encyclopedia
View More
name
Aier
300015.SZ
Aier Eye Hospital Group Co., Ltd. operates as a ophthalmology chain medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. The company offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and glasses for fundus diseases, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment.
175.65 B
300015.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Health Care FacilitiesIndustry
Industry Ranking1/9
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE15.03%A
    • Profit Margin14.52%B
    • Gross Margin50.66%B
  • Growth ScoreC
    • Revenue YoY7.49%B
    • Net Profit YoY-11.31%D
    • Total Assets YoY8.66%B
    • Net Assets YoY10.60%B
  • Cash ScoreB
    • Cash Flow Margin688.57%C
    • OCF YoY7.49%B
  • Operating ScoreB
    • Turnover0.64B
  • Debt ScoreB
    • Gearing Ratio33.53%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Aier Eye Hospital Group Co., Ltd. Appoints Liu Duan and Tian Suhua as Independent Director

    Aier Eye Hospital Group Co., Ltd. appointed Liu Duan and Tian Suhua as independent director at its EGM held on 27 November 2025. .

    marketscreener·
    SZ
    300015
    +0.62%
    marketscreener·
    SZ
    300015
    +0.62%

    Aier Eye Hospital Group Co., Ltd. Approves Interim Dividend of Year 2025

    Aier Eye Hospital Group Co., Ltd. at its EGM held on 27 November 2025, the company approved 2025 interim profit distribution plan as Cash dividend/10 shares (tax included) of CNY 0.80000000 per share.

    marketscreener·
    SZ
    300015
    +0.62%
    marketscreener·
    SZ
    300015
    +0.62%

    Aier Eye Hospital Group Co., Ltd. Proposes Interim Profit Distribution Plan for 2025

    Aier Eye Hospital Group Co., Ltd. announced that at the EGM to be held on 27 November 2025, the company proposed 2025 interim profit distribution plan as Cash dividend/10 shares (tax included): CNY 0.80000000.

    marketscreener·
    SZ
    300015
    +0.62%
    marketscreener·
    SZ
    300015
    +0.62%

    Aier Eye Hospital announces interim dividend plan

    Aier Eye Hospital announces interim dividend plan

    marketscreener·
    SZ
    300015
    +0.62%
    marketscreener·
    SZ
    300015
    +0.62%

    Aier Eye Hospital released its performance for the first three quarters, with a net profit attributable to the parent company of 3.115 billion yuan, a decrease of 9.76%

    According to the Zhitong Finance APP, Aier released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 17.484 billion yuan, a year-on-year increase of 7.25%. The net profit attributable to shareholders of the listed company was 3.115 billion yuan, a year-on-year decrease of 9.76%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 3.119 billion yuan, a year-on-year increase of 0.20%. The basic earnings per share were 0.337 yuan

    Zhitong·
    SZ
    300015
    +0.62%
    Zhitong·
    SZ
    300015
    +0.62%
    © 2025 Longbridge｜Disclaimer